Correlation Between Knight Therapeutics and Covalon Technologies

Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Knight Therapeutics and Covalon Technologies, you can compare the effects of market volatilities on Knight Therapeutics and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Covalon Technologies.

Diversification Opportunities for Knight Therapeutics and Covalon Technologies

-0.66

Correlation Coefficient

Knight Therapeutics  Covalon Technologies

Excellent diversification

The 3 months correlation between Knight and Covalon is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Covalon Technologies go up and down completely randomly.

Pair Corralation between Knight Therapeutics and Covalon Technologies

Assuming the 90 days trading horizon Knight Therapeutics is expected to under-perform the Covalon Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Knight Therapeutics is 1.37 times less risky than Covalon Technologies. The stock trades about -0.02 of its potential returns per unit of risk. The Covalon Technologies is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  310.00  in Covalon Technologies on September 3, 2024 and sell it today you would earn a total of  55.00  from holding Covalon Technologies or generate 17.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Knight Therapeutics  vs.  Covalon Technologies

Knight Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Covalon Technologies

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Covalon Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Knight Therapeutics and Covalon Technologies

The main advantage of trading using opposite Knight Therapeutics and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.

The idea behind Knight Therapeutics and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.